MMP3 -1171 5A/6A Promoter Genotype Influences Serum MMP3 Levels and Is Associated with Deep Venous Thrombosis

Xiang-Ping Li1, Guang-Zhen Wan2, Guang-Jian Wang3

  • 1Department of Emergency Orthopedics, Linyi People's Hospital of Shandong Province, Linyi, Shandong, P.R. China.

Abstract

Insights

Matrix metalloproteinase-3 (MMP3) gene polymorphism and increased protein expression are linked to a higher risk of deep venous thrombosis (DVT) in the Chinese Han population. The 6A allele of MMP3 -1171 5A>6A may increase DVT susceptibility.

Area of Science:

  • Genetics
  • Molecular Biology
  • Vascular Medicine

Background:

  • Deep venous thrombosis (DVT) is a significant vascular condition.
  • The role of matrix metalloproteinase-3 (MMP3) in DVT pathogenesis requires further investigation.
  • Genetic variations and protein expression levels of MMP3 may influence DVT risk.

Purpose of the Study:

  • To examine the association between MMP3 gene polymorphism (-1171 5A>6A) and protein expression with DVT in the Chinese Han population.
  • To determine if specific MMP3 genotypes or alleles correlate with an increased risk of developing DVT.
  • To assess MMP3 serum levels in DVT patients compared to healthy controls.

Main Methods:

  • Genotyping of the MMP3 -1171 5A>6A promoter polymorphism using polymerase chain reaction-restriction fragment length polymorphism.
  • Quantification of MMP3 serum levels via enzyme-linked immunosorbent assay.
  • Statistical analysis of genotype frequencies, allele frequencies, and serum protein levels in 280 subjects (144 DVT patients, 136 controls).

Main Results:

  • Significant differences in MMP3 -1171 5A>6A genotype frequencies were observed between DVT patients and controls (P < 0.05).
  • The 6A allele of MMP3 -1171 5A>6A was associated with an elevated risk of DVT (OR = 1.961, P < 0.01).
  • MMP3 serum levels were significantly higher in DVT patients compared to controls (P < 0.05), particularly in those with 5A/6A and 6A/6A genotypes.

Conclusions:

  • MMP3 gene -1171 5A>6A polymorphism is associated with DVT risk in the Chinese Han population.
  • Upregulated MMP3 protein expression may play a role in the development of DVT.
  • These findings suggest MMP3 as a potential genetic and molecular marker for DVT risk assessment.

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
422
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.6K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
655
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
459